MediciNova Management
Management criteria checks 2/4
MediciNova's CEO is Yuichi Iwaki, appointed in Jan 2000, has a tenure of 24.83 years. total yearly compensation is $1.39M, comprised of 47.4% salary and 52.6% bonuses, including company stock and options. directly owns 2.23% of the company’s shares, worth ¥338.26M. The average tenure of the management team and the board of directors is 8.3 years and 5.3 years respectively.
Key information
Yuichi Iwaki
Chief executive officer
US$1.4m
Total compensation
| CEO salary percentage | 47.4% |
| CEO tenure | 24.8yrs |
| CEO ownership | 2.2% |
| Management average tenure | 8.3yrs |
| Board average tenure | 5.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$10m |
| Jun 30 2024 | n/a | n/a | -US$8m |
| Mar 31 2024 | n/a | n/a | -US$8m |
| Dec 31 2023 | US$1m | US$657k | -US$9m |
| Sep 30 2023 | n/a | n/a | -US$10m |
| Jun 30 2023 | n/a | n/a | -US$12m |
| Mar 31 2023 | n/a | n/a | -US$14m |
| Dec 31 2022 | US$1m | US$620k | -US$14m |
| Sep 30 2022 | n/a | n/a | -US$13m |
| Jun 30 2022 | n/a | n/a | -US$13m |
| Mar 31 2022 | n/a | n/a | -US$13m |
| Dec 31 2021 | US$3m | US$596k | -US$10m |
| Sep 30 2021 | n/a | n/a | -US$11m |
| Jun 30 2021 | n/a | n/a | -US$11m |
| Mar 31 2021 | n/a | n/a | -US$11m |
| Dec 31 2020 | US$3m | US$587k | -US$14m |
| Sep 30 2020 | n/a | n/a | -US$13m |
| Jun 30 2020 | n/a | n/a | -US$12m |
| Mar 31 2020 | n/a | n/a | -US$11m |
| Dec 31 2019 | US$4m | US$572k | -US$13m |
| Sep 30 2019 | n/a | n/a | -US$11m |
| Jun 30 2019 | n/a | n/a | -US$16m |
| Mar 31 2019 | n/a | n/a | -US$15m |
| Dec 31 2018 | US$3m | US$551k | -US$15m |
| Sep 30 2018 | n/a | n/a | -US$16m |
| Jun 30 2018 | n/a | n/a | -US$13m |
| Mar 31 2018 | n/a | n/a | -US$13m |
| Dec 31 2017 | US$3m | US$534k | -US$11m |
Compensation vs Market: Yuichi's total compensation ($USD1.39M) is above average for companies of similar size in the JP market ($USD930.75K).
Compensation vs Earnings: Yuichi's compensation has increased whilst the company is unprofitable.
CEO
Yuichi Iwaki (74 yo)
24.8yrs
Tenure
US$1,388,309
Compensation
Dr. Yuichi Iwaki, M.D., Ph D., is a Co-Founder of MediciNova Inc. and has been its Chief Executive Officer and President since March 2006. Dr. Iwaki served as Acting Principal Financial Officer at MediciNo...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 24.8yrs | US$1.39m | 2.23% ¥ 338.3m | |
| Chief Medical Officer & Director | 13.2yrs | US$1.01m | 0.66% ¥ 100.1m | |
| CFO & Principal Financial Officer | 2.4yrs | no data | no data | |
| Chief Business Officer | 3.5yrs | no data | no data | |
| Controller | no data | no data | no data |
8.3yrs
Average Tenure
58.5yo
Average Age
Experienced Management: 4875's management team is seasoned and experienced (8.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 24.2yrs | US$1.39m | 2.23% ¥ 338.3m | |
| Chief Medical Officer & Director | 5.3yrs | US$1.01m | 0.66% ¥ 100.1m | |
| Independent Director | 7yrs | US$69.23k | 0% ¥ 0 | |
| Independent Director | 4.1yrs | US$69.23k | 0% ¥ 0 | |
| Independent Director | 1.3yrs | US$46.16k | 0% ¥ 0 |
5.3yrs
Average Tenure
66yo
Average Age
Experienced Board: 4875's board of directors are considered experienced (5.3 years average tenure).